Schonewille H - Search Results

1

Reduction of anti-K-mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation-wide policy change evaluation study in the Netherlands.

Luken JS, Folman CC, Lukens MV, Meekers JH, Ligthart PC, Schonewille H, Zwaginga JJ, Janssen MP, van der Schoot CE, van der Bom JG, de Haas M. Luken JS, et al. Among authors: schonewille h. Transfusion. 2021 Mar;61(3):713-721. doi: 10.1111/trf.16276. Epub 2021 Feb 2. Transfusion. 2021. PMID: 33528025 Free PMC article.

2

Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases.

Schonewille H, Haak HL, van Zijl AM. Schonewille H, et al. Transfusion. 1999 Jul;39(7):763-71. doi: 10.1046/j.1537-2995.1999.39070763.x. Transfusion. 1999. PMID: 10413286

3

RBC antibody persistence.

Schonewille H, Haak HL, van Zijl AM. Schonewille H, et al. Transfusion. 2000 Sep;40(9):1127-31. doi: 10.1046/j.1537-2995.2000.40091127.x. Transfusion. 2000. PMID: 10988317

4

The importance of antibodies against low-incidence RBC antigens in complete and abbreviated cross-matching.

Schonewille H, van Zijl AM, Wijermans PW. Schonewille H, et al. Transfusion. 2003 Jul;43(7):939-44. doi: 10.1046/j.1537-2995.2003.t01-1-00435.x. Transfusion. 2003. PMID: 12823754

5

Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity.

Schonewille H, van de Watering LM, Loomans DS, Brand A. Schonewille H, et al. Transfusion. 2006 Feb;46(2):250-6. doi: 10.1111/j.1537-2995.2006.00708.x. Transfusion. 2006. PMID: 16441603

6

Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?

Schonewille H, van de Watering LM, Brand A. Schonewille H, et al. Transfusion. 2006 Apr;46(4):630-5. doi: 10.1111/j.1537-2995.2006.00764.x. Transfusion. 2006. PMID: 16584440

7

High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus.

Schonewille H, Klumper FJ, van de Watering LM, Kanhai HH, Brand A. Schonewille H, et al. Am J Obstet Gynecol. 2007 Feb;196(2):143.e1-6. doi: 10.1016/j.ajog.2006.10.895. Am J Obstet Gynecol. 2007. PMID: 17306657

8

Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens?

Schonewille H, Brand A. Schonewille H, et al. Transfusion. 2008 May;48(5):958-63. doi: 10.1111/j.1537-2995.2008.01659.x. Transfusion. 2008. PMID: 18454736

9

Alloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients.

Schonewille H, de Vries RR, Brand A. Schonewille H, et al. Transfusion. 2009 Mar;49(3):453-7. doi: 10.1111/j.1537-2995.2008.01980.x. Transfusion. 2009. PMID: 19243541

10

Red blood cell alloimmunization in sickle cell disease patients in Uganda.

Natukunda B, Schonewille H, Ndugwa C, Brand A. Natukunda B, et al. Among authors: schonewille h. Transfusion. 2010 Jan;50(1):20-5. doi: 10.1111/j.1537-2995.2009.02435.x. Epub 2009 Oct 10. Transfusion. 2010. PMID: 19821949

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page